Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | +Grant/Award | $0 | +161,160 | $0.00 | 161,160 | Feb 27, 2024 | Common Stock | 161,160 | $26.89 | Direct | F1 | |
transaction | PFE | Stock Appreciation Rights | +Grant/Award | $0 | +142,400 | $0.00 | 142,400 | Feb 27, 2024 | Common Stock | 142,400 | $26.89 | Direct | F2 |
Id | Content |
---|---|
F1 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
F2 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |